Research programme: controlled-release stem cell therapeutics - Cell Care Therapeutics
Latest Information Update: 18 Jan 2016
At a glance
- Originator Cell Care Therapeutics
- Class Cell therapies
- Mechanism of Action Cell replacements
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Research Eye disorders
Most Recent Events
- 14 Jan 2016 Early research in Eye disorders in USA (unspecified route)